|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Verve Therapeutics, Inc. (VERV) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
89,140,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Verve Therapeutics is a genetic medicines company developing an approach to the care of cardiovascular disease, transforming treatment from chronic management to single-course gene editing medicines. Co.'s primary product candidate, VERVE-101, is designed to turn off the PCSK9 gene in the liver. PCSK9 is a validated target that plays a critical role in controlling blood low-density lipoprotein cholesterol through its regulation of the low-density lipoprotein receptor. Co.'s second program is designed to turn off the ANGPTL3 gene in the liver. ANGPTL3 is a main regulator of cholesterol and triglyceride metabolism.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
1,876,000 |
| Total Buy Value |
$0 |
$0 |
$0 |
$18,475,760 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
0 |
24,054 |
24,609 |
26,677 |
| Total Sell Value |
$0 |
$99,824 |
$102,954 |
$121,772 |
| Total People Sold |
0 |
6 |
6 |
6 |
| Total Sell Transactions |
0 |
6 |
7 |
9 |
| End Date |
2025-05-22 |
2025-02-18 |
2024-08-20 |
2023-08-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Yeshwant Krishna |
|
– • • |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,168,489) |
0 |
|
- |
|
| Kathiresan Sekar |
Chief Executive Officer |
• • – |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(351,994) |
0 |
|
- |
|
| Kathiresan Sekar |
Chief Executive Officer |
• • – |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(348,431) |
0 |
|
- |
|
| Dorval Allison |
Chief Financial Officer |
• – – |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(13,280) |
0 |
|
- |
|
| Politi Jason |
Chief Technical Ops. Off. |
• – – |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(16,405) |
0 |
|
- |
|
| Ashe Andrew D. |
See Remarks |
• – – |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(348,828) |
0 |
|
- |
|
| Adelman Burt A |
|
– • – |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(428,326) |
0 |
|
- |
|
| Nickerson Joan |
Chief Administrative Officer |
• – – |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,420) |
0 |
|
- |
|
| Alphabet Inc. |
10% Owner |
– – • |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
I/I |
(12,168,489) |
0 |
|
- |
|
| Lister Troy |
Chief Scientific Officer |
• – – |
2025-07-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(6,952) |
0 |
|
- |
|
| Nickerson Joan |
Chief Administrative Officer |
• – – |
2025-04-02 |
4 |
S |
$4.15 |
$11,525 |
D/D |
(2,777) |
17,420 |
|
- |
|
| Politi Jason |
Chief Technical Ops. Off. |
• – – |
2025-04-02 |
4 |
S |
$4.15 |
$13,425 |
D/D |
(3,235) |
14,226 |
|
- |
|
| Lister Troy |
Chief Scientific Officer |
• – – |
2025-04-02 |
4 |
S |
$4.15 |
$9,084 |
D/D |
(2,189) |
6,952 |
|
- |
|
| Ashe Andrew D. |
See Remarks |
• – – |
2025-04-02 |
4 |
S |
$4.15 |
$11,126 |
D/D |
(2,681) |
348,828 |
|
- |
|
| Kathiresan Sekar |
Chief Executive Officer |
• • – |
2025-04-02 |
4 |
S |
$4.15 |
$40,761 |
D/D |
(9,822) |
346,686 |
|
- |
|
| Dorval Allison |
Chief Financial Officer |
• – – |
2025-04-02 |
4 |
S |
$4.15 |
$13,903 |
D/D |
(3,350) |
13,280 |
|
- |
|
| Nickerson Joan |
Chief Administrative Officer |
• – – |
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,315 |
20,197 |
|
- |
|
| Politi Jason |
Chief Technical Ops. Off. |
• – – |
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,815 |
17,461 |
|
- |
|
| Lister Troy |
Chief Scientific Officer |
• – – |
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,340 |
9,141 |
|
- |
|
| Ashe Andrew D. |
See Remarks |
• – – |
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,000 |
351,509 |
|
- |
|
| Kathiresan Sekar |
Chief Executive Officer |
• • – |
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
33,000 |
356,508 |
|
- |
|
| Dorval Allison |
Chief Financial Officer |
• – – |
2025-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,250 |
16,630 |
|
- |
|
| Kathiresan Sekar |
Chief Executive Officer |
• • – |
2024-12-04 |
4 |
GA |
$0.00 |
$0 |
I/I |
30,000 |
110,997 |
|
- |
|
| Kathiresan Sekar |
Chief Executive Officer |
• • – |
2024-12-04 |
4 |
GD |
$0.00 |
$0 |
D/D |
30,000 |
323,508 |
|
- |
|
| Dorval Allison |
Chief Financial Officer |
• – – |
2024-12-02 |
4 |
S |
$5.64 |
$3,130 |
D/D |
(555) |
5,380 |
|
- |
|
127 Records found
|
|
Page 1 of 6 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
